Intimation regarding dispatch of letter containing web link of Annual Report 2025-2026 pursuant to Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015.

Date: 28.07.2026 Department of Corporate Services, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524748 Dear Sir/Madam, Sub: Dispatch of letter containing web link of Annual Report pursuant to Regulation 36(1)(b) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. We wish to inform you that, Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company has dispatched a letter containing a web-link of the Annual Report 2025-2026 to those shareholders who have not registered their email addresses with the Company/Registrar & Share Transfer Agent (‘RTA’)/Depository Participant(s) (‘DPs’). A copy of the letter is enclosed herewith for your record. Kindly take the same on your record. Thanking you, For Link Pharma Chem Limited Komal Bhojwani Company Secretary & Compliance Officer Membership No.: A65594 REGISTERED OFFICE: Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat) (India) Tel. (O) 9925057946 E-Mail: linkpharmacs@gmail.com CIN: L24230GJ1984PLC007540 Website: www.linkpharmachem.co.in Date : 27/07/2026 Ref : 60 BHARAT JETHALAL PANCHAL 103, KSHITIJ CO - OP HSG SOC, KAKAD KUNG MARG, KANDIVALI (W) MUMBAI 400067 Sub.: Notice of 41st Annual General Meeting (AGM) of Link Pharma Chem Limited and Annual Report for the Financial Year 2025-2026. We are pleased to inform you that the 41st Annual General Meeting ('AGM') of the Members of Link Pharma Chem Limited (‘the Company’) is scheduled to be held on Thursday, 20th August, 2026 AT 11:30 A.M (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations, 2015’), as amended, the web-link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), Registrar & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the exact path where complete details of the Annual Report for the Financial Year 2025-2026 are available at: Website: https://linkpharmachem.co.in Exact path of Annual Report 2025-2026: https://linkpharmachem.co.in/wp-content/uploads/2026/07/41st-Annual-Report- 2025-26.pdf. Key details for the AGM are as under: Sr no. Particulars Dates 1. Cut-off date for e-Voting and AGM participation Thursday, 13th August, 2026 2. Remote e-Voting start date and time Monday, 17th August, 2026 at 09.00 am (IST) 3. Remote e-Voting end date and time Wednesday, 19th August, 2026 at 5.00 pm (IST) 4. Date of AGM Thursday, 20th August, 2026 at 11:30 am (IST) This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on 24th July, 2026. This is also a reminder to update KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD- 1/P/CIR/2024/37 dated May 07, 2024, and to dematerialise physical securities. The circular issued by SEBI mandates all the listed companies to record PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature and choice of Nomination of security holders holding securities in physical mode. While updating Email ID is optional, the security holders are requested to register email id also to avail online services. This is applicable for all security holders holding securities in physical mode. The formats for choice of Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI circulars are available on our website as mentioned below: https://www.in.mpms.mufg.com > Resources > Downloads > KYC > Formats for KYC. The aforesaid SEBI Circular also mandates that security holders holding in physical mode whose folios do not have PAN, Choice of Nomination, Contact details, Bank Account details and Specimen Signature updated, shall be eligible for any payment including dividend, interest or redemption payment in respect of such folios, only through electronic mode with effect from April 1, 2024. Should you have any queries, please feel free to contact our investor relations department at Email Id: investor.helpdesk@mpms.mufg.com or Tel: (+91) 265 3566768. Moreover, you are also requested to update your e mail address at the earliest either through your depository participants for electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yours faithfully,For Link Pharma Chem Limited For Link Pharma Chem Limited Sd/- Satish G. Thakur Chairman & Whole-time Director (DIN: 00292129) REGISTERED OFFICE: Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat) (India) Tel. (O) 9925057946 E-Mail: linkpharmacs@gmail.com CIN: L24230GJ1984PLC007540 Website: www.linkpharmachem.co.in Date : 27/07/2026 Ref : 61 ALKADEVI JHAWAR . W/O VASUDEV JHAWAR H NO. 2-5-215 , OPP. JAWAHAR NAGAR HIGH SCHOOL, JAWAHAR NAG RAICHUR 584101 Sub.: Notice of 41st Annual General Meeting (AGM) of Link Pharma Chem Limited and Annual Report for the Financial Year 2025-2026. We are pleased to inform you that the 41st Annual General Meeting ('AGM') of the Members of Link Pharma Chem Limited (‘the Company’) is scheduled to be held on Thursday, 20th August, 2026 AT 11:30 A.M (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations, 2015’), as amended, the web-link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), Registrar & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the exact path where complete details of the Annual Report for the Financial Year 2025-2026 are available at: Website: https://linkpharmachem.co.in Exact path of Annual Report 2025-2026: https://linkpharmachem.co.in/wp-content/uploads/2026/07/41st-Annual-Report- 2025-26.pdf. Key details for the AGM are as under: Sr no. Particulars Dates 1. Cut-off date for e-Voting and AGM participation Thursday, 13th August, 2026 2. Remote e-Voting start date and time Monday, 17th August, 2026 at 09.00 am (IST) 3. Remote e-Voting end date and time Wednesday, 19th August, 2026 at 5.00 pm (IST) 4. Date of AGM Thursday, 20th August, 2026 at 11:30 am (IST) This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on 24th July, 2026. This is also a reminder to update KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD- 1/P/CIR/2024/37 dated May 07, 2024, and to dematerialise physical securities. The circular issued by SEBI mandates all the listed companies to record PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature and choice of Nomination of security holders holding securities in physical mode. While updating Email ID is optional, the security holders are requested to register email id also to avail online services. This is applicable for all security holders holding securities in physical mode. The formats for choice of Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI circulars are available on our website as mentioned below: https://www [Showing first 8,000 characters — download PDF for full document]